What type of study is this?

September 10, 2025Frontiers in ImmunologyOpen Access

Efgartigimod in the treatment of Guillain-Barré syndrome: case report

View Full Paper

Ask AI

Bookmark

Authors

Case report finds favorable outcomes with efgartigimod in acute guillain-barré syndrome, suggesting new treatment avenues.

Efgartigimod shows promise as a treatment for acute guillain-barré syndrome, improving patient outcomes.
Among four patients treated, two had favorable responses without additional immunotherapies, exploring treatment efficacy.
The observational framework includes case reports on acute guillain-barré syndrome patients in clinical settings.
These findings highlight the need for further studies to fully establish efgartigimod's effectiveness for broader GBS applications.

Deng et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark